Globus Medical Reports Third Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Globus Medical (GMED) Tops Q3 EPS by 19c
October 28, 2020 4:37 PM EDTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.49, $0.19 better than the analyst estimate of $0.30. Revenue for the quarter came in at $216.1 million versus the consensus estimate of $195.87 million.
The Globus Team executed extremely well in the third quarter, delivering record revenue, record earnings per share and... More
